Chromai
Shanghai, China· Est.
Chromai focuses on developing CRISPR-based gene editing therapies for genetic disorders and oncology applications.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
About
Chromai focuses on developing CRISPR-based gene editing therapies for genetic disorders and oncology applications.
CRISPRGenetics & GenomicsOncology